Apr 27, 2026 05:37PM
Apr 27, 2026 05:37PM
Mar 14, 2026 04:30AM
Mar 14, 2026 04:30AM
Oct 6, 2025 04:03PM
Oct 6, 2025 04:03PM
Sep 16, 2025 07:02AM Biomea Fusion presents preclinical data on diabetes drug combination
Sep 16, 2025 07:00AM
Aug 5, 2025 04:05PM
May 5, 2025 04:05PM
Mar 31, 2025 04:10PM
Jan 13, 2025 09:00AM
Jan 13, 2025 09:00AM
Dec 17, 2024 08:10AM Biomea Fusion, Inc. (BMEA) Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes
Dec 17, 2024 08:10AM
Dec 9, 2024 04:03PM
Dec 9, 2024 04:01PM
Dec 6, 2024 08:00AM
Nov 18, 2024 08:00AM
Oct 29, 2024 04:46PM
Oct 7, 2024 09:00AM Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
Oct 1, 2024 09:03AM
Oct 1, 2024 09:00AM
Sep 27, 2024 09:10AM
Sep 27, 2024 09:07AM
Sep 27, 2024 08:41AM
Sep 27, 2024 06:44AM
Sep 26, 2024 02:00PM FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
Jul 31, 2024 04:05PM
Jul 3, 2024 03:18PM
Jun 17, 2024 09:00AM
Jun 16, 2024 03:56PM
Jun 10, 2024 05:39AM
Jun 7, 2024 07:25AM
Jun 6, 2024 04:06PM Biomea Fusion (BMEA) Announces Clinical Hold on Trial of BMF-219 in Diabetes
Jun 6, 2024 04:05PM
Jun 6, 2024 04:05PM
Apr 1, 2024 09:00AM
Jan 9, 2024 11:04AM
Jan 9, 2024 11:02AM
Dec 5, 2023 08:30AM
Oct 30, 2023 04:01PM Biomea Fusion Reports Third Quarter 2023 Financial Results and Corporate Highlights
Oct 17, 2023 08:30AM
Oct 5, 2023 08:30AM
Oct 5, 2023 08:30AM
Sep 28, 2023 08:33AM
Sep 28, 2023 08:30AM
Jun 26, 2023 06:58AM
Jun 23, 2023 09:54PM Biomea Fusion Presents Positive Clinical Data from the Initial Cohorts of the Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes Mellitus at the American Diabetes Associ
May 1, 2023 08:32AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All